The ‘Trickle-Down’ Effect of Corruption in China’s Medical Industry

Patients in China are getting ripped off because 90 percent of all prescription drugs are overpriced.
The ‘Trickle-Down’ Effect of Corruption in China’s Medical Industry
Customers buy goods in an independent pharmacy in Hong Kong on Nov. 18, 2013. Ninety percent of all prescription drugs in China are overpriced, according to a Party official. Anthony Wallace/AFP/Getty Images
Frank Fang
Frank Fang
Reporter
|Updated:

Going to the hospital in China is often a distressing affair. Despite efforts by government regulators, ordinary Chinese have been paying ever greater sums for prescription drugs, a phenomenon brought about by widespread, multi-faceted corruption in the medical system.

As reported by state media Xinhua News Agency on March 9, ninety percent of all Chinese prescription drugs are overpriced, said Wei Feiyan, president of a southern Chinese pharmaceutical company.

According to Wei, there “wouldn’t be a problem” if drug costs were lowered by half or more.

Zhang Fuwei, deputy director of a hospital in Guangxi, said that kickbacks in pharmaceutical companies contributed to the high prices in medicine. The higher the price of a product, the more kickback.

Some new drugs, though are less effective, might be used in the hospital because they offer expensive kickbacks.
Dr. Yang, China Academy of Chinese Medical Sciences
Frank Fang
Frank Fang
Reporter
Frank Fang is a Taiwan-based reporter. He covers U.S., China, and Taiwan news. He holds a master's degree in materials science from Tsinghua University in Taiwan.
twitter
Related Topics